Autologous blood derived cell therapy in maxillofacial bone graft surgery
¹ÚÁÖ¿µ,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÁÖ¿µ ( Park Joo-Young ) - Seoul National University School of Dentistry Department of Oral and Maxillofacial Surgery
Abstract
Tissue regeneration is one of the ultimate goals of maxillofacial surgery and various types of tissue engineering technologies have been utilized in clinics. Healthy resources of host cells and growth factors are essential for the tissue engineering, therefore autologous blood-derived cell therapy was introduced. In this article, clinical applications of the autologous platelet concentrates and stem cell separation therapy will be summarized and evaluated for their efficacy and feasibility in the current maxillofacial clinics.
Å°¿öµå
Tissue engineering; Regeneration; Maxilla; Mandible; Autografts
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸